Related Experiment Videos
Sarcomas of the breast
1Hedle Atkins Breast Unit, Guy's Hospital, London, UK.
International Journal of Clinical Practice
|January 10, 2004
Summary
Breast sarcomas, rare stromal cell tumors, exhibit varied behavior from benign to malignant. Treatment focuses on wide surgical excision, as spread is hematogenous, and radiotherapy is not effective for these rare breast cancers.
Area of Science:
- Oncology
- Surgical Pathology
Background:
- Breast sarcomas are rare malignant tumors originating from mammary stromal cells.
- Phyllodes tumors can mimic fibroadenomas but occur in older patients, with unpredictable behavior ranging from benign to malignant.
- Sarcomas primarily spread hematogenously, not via lymphatics, necessitating distinct treatment approaches.
Purpose of the Study:
- To review the characteristics and management of breast sarcomas.
- To highlight the differences between various types of breast sarcomas, such as phyllodes tumors and angiosarcomas.
- To emphasize the importance of surgical margins and the limited role of radiotherapy.
Main Methods:
- Review of existing literature on breast sarcomas.
- Analysis of histological features and clinical behavior.
- Discussion of treatment strategies including surgery, radiotherapy, and chemotherapy.
Main Results:
- Breast sarcomas are rare and diverse, with behavior not always predictable histologically.
- Hematogenous spread is characteristic, making axillary surgery unnecessary.
- Angiosarcoma can arise after radiation therapy; fibrosarcomas require wide margins to prevent local recurrence.
Conclusions:
- Wide surgical clearance is the cornerstone of breast sarcoma treatment.
- Radiotherapy is generally ineffective, while chemotherapy may palliate metastatic disease.
- Accurate diagnosis and appropriate surgical management are crucial for improving outcomes in breast sarcoma patients.